OCON Therapeutics
OCON Therapeutics52
OCON Therapeutics
OCON Healthcare develops and commercializes innovative women's health products based on its patented IUB® (Intra Uterine Ball) platform.
About
What does OCON Therapeutics do?
OCON Healthcare is a medical device company focused on women's health. They innovate, develop, manufacture, and commercialize cutting-edge products utilizing their patented IUB® (Intra Uterine Ball) proprietary platform. The IUB®, made from a super-elastic Nitinol alloy, serves as an ideal carrier for multiple drugs to the uterus to treat various conditions.
What is OCON Therapeutics's revenue?
StartupHub estimates OCON Therapeutics's annual revenue at $5.6M (range $3.3M to $12.3M, 68% confidence), based on comparable companies in the sector.
What is OCON Therapeutics's valuation?
StartupHub estimates OCON Therapeutics's effective valuation at $48.5M (range $30.0M to $72.0M, 16% confidence), based on comparable companies in the sector.
How much funding has OCON Therapeutics raised?
OCON Therapeutics has raised a total of $12M in funding. The most recent round on record is Seed.
Where is OCON Therapeutics headquartered?
OCON Therapeutics is headquartered in Modi'in, Israel.
When was OCON Therapeutics founded?
OCON Therapeutics was founded in 2011.
What industry does OCON Therapeutics operate in?
OCON Therapeutics operates in Healthcare, Medical Device, FemTech, Drug Delivery, MedTech, HealthTech.
How many employees does OCON Therapeutics have?
OCON Therapeutics has approximately 29 people on record.
Does OCON Therapeutics have an affiliate program?
Yes, OCON Therapeutics has an affiliate program. The program runs on Self-hosted affiliate. Register here: https://oconmed.com/affiliates
OCON Therapeutics's IUB platform can serve as a drug delivery system, which could be utilized by IVF centers for various fertility treatments.
OCON Therapeutics develops and commercializes innovative women's health products, which hospitals would be interested in for their gynecology and women's health departments.
OCON Therapeutics's IUB platform could be used to deliver drugs for various conditions, making ART laboratories potential clients for their specialized needs in reproductive technology.
OCON Therapeutics's IUB platform is a proprietary drug delivery system, which fertility pharma companies could leverage for their own drug formulations aimed at women's health.
OCON Therapeutics's focus on women's health medical devices, particularly with its IUB platform, aligns with the product portfolios and development interests of gynecology and laparoscopy medical device companies.
Buyer fit inferred by StartupHub from what OCON Therapeutics sells and public signals about each company. Only rows badged "already a customer" are confirmed relationships.
Meril Life Sciences, a medical device company focused on innovative healthcare solutions, could fold OCON Therapeutics's IUB platform into its existing portfolio of advanced surgical products, particularly those related to women's health an
Flo Health, a major player in the FemTech market with a focus on menstrual and reproductive health, could integrate OCON Therapeutics's IUB platform to expand its offerings beyond apps and wearables into medical devices for drug delivery.
Ava Science Inc., a FemTech market leader, could acquire OCON Therapeutics to broaden its product line in women's health beyond fertility tracking wearables to include innovative drug delivery medical devices.
Elvie, a company known for its postpartum devices and women's health technology, could acquire OCON Therapeutics to diversify its offerings into intrauterine drug delivery systems, complementing its existing focus on women's health medical
Willow Innovations, a FemTech company specializing in wearable breast pumps, could acquire OCON Therapeutics to expand its women's health portfolio into other critical areas like intrauterine drug delivery, leveraging OCON's patented IUB pl
Strategic fit inferred by StartupHub from each buyer's own acquisition history. No deal, approach or discussion is implied.
Designs, manufactures, and markets medical devices for diabetes care, wound care, and drug delivery.
Manufacturer and supplier of laboratory consumables, instruments, and chemicals in India.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
An entrant is a company tagged Drug Delivery whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
“Ballerine IUD in Ireland. https://www.consilienthealth.ie/ocon-therapeutics-will-cease-the-supply-of-ballerine-in-ireland/ Does anyone have any ideas about why this is happening/what caused it?”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.